177 related articles for article (PubMed ID: 23924802)
1. Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency.
Rivera-Hernández G; Marin-Argany M; Blasco-Moreno B; Bonet J; Oliva B; Villegas S
MAbs; 2013; 5(5):678-89. PubMed ID: 23924802
[TBL] [Abstract][Full Text] [Related]
2. Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential.
Montoliu-Gaya L; Murciano-Calles J; Martinez JC; Villegas S
Amyloid; 2017 Sep; 24(3):167-175. PubMed ID: 28699800
[TBL] [Abstract][Full Text] [Related]
3. Contributions of a highly conserved VH/VL hydrogen bonding interaction to scFv folding stability and refolding efficiency.
Tan PH; Sandmaier BM; Stayton PS
Biophys J; 1998 Sep; 75(3):1473-82. PubMed ID: 9726949
[TBL] [Abstract][Full Text] [Related]
4. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
[TBL] [Abstract][Full Text] [Related]
5. Understanding the contribution of disulfide bridges to the folding and misfolding of an anti-Aβ scFv.
Montoliu-Gaya L; Martínez JC; Villegas S
Protein Sci; 2017 Jun; 26(6):1138-1149. PubMed ID: 28340507
[TBL] [Abstract][Full Text] [Related]
6. Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability.
Wörn A; Plückthun A
Biochemistry; 1998 Sep; 37(38):13120-7. PubMed ID: 9748318
[TBL] [Abstract][Full Text] [Related]
7. Stability engineering of anti-EGFR scFv antibodies by rational design of a lambda-to-kappa swap of the VL framework using a structure-guided approach.
Lehmann A; Wixted JH; Shapovalov MV; Roder H; Dunbrack RL; Robinson MK
MAbs; 2015; 7(6):1058-71. PubMed ID: 26337947
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic parameters and mechanism of action of an efficient anti-Aβ single chain antibody fragment.
Esquerda-Canals G; Martí-Clúa J; Villegas S
PLoS One; 2019; 14(5):e0217793. PubMed ID: 31150495
[TBL] [Abstract][Full Text] [Related]
9. The Antibody Light-Chain Linker Is Important for Domain Stability and Amyloid Formation.
Nokwe CN; Hora M; Zacharias M; Yagi H; John C; Reif B; Goto Y; Buchner J
J Mol Biol; 2015 Nov; 427(22):3572-3586. PubMed ID: 26408269
[TBL] [Abstract][Full Text] [Related]
10. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
11. Construction, expression, purification, refold and activity assay of a specific scFv fragment against foot and mouth disease virus.
ShengFeng C; Ping L; Tao S; Xin W; GuoFeng W
Vet Res Commun; 2003 Apr; 27(3):243-56. PubMed ID: 12777098
[TBL] [Abstract][Full Text] [Related]
12. Restricted V gene usage and VH/VL pairing of mouse humoral response against the N-terminal immunodominant epitope of the amyloid β peptide.
Robert R; Lefranc MP; Ghochikyan A; Agadjanyan MG; Cribbs DH; Van Nostrand WE; Wark KL; Dolezal O
Mol Immunol; 2010; 48(1-3):59-72. PubMed ID: 20970857
[TBL] [Abstract][Full Text] [Related]
13. Cyclization of Single-Chain Fv Antibodies Markedly Suppressed Their Characteristic Aggregation Mediated by Inter-Chain VH-VL Interactions.
Yamauchi S; Kobashigawa Y; Fukuda N; Teramoto M; Toyota Y; Liu C; Ikeguchi Y; Sato T; Sato Y; Kimura H; Masuda T; Ohtsuki S; Noi K; Ogura T; Morioka H
Molecules; 2019 Jul; 24(14):. PubMed ID: 31323851
[TBL] [Abstract][Full Text] [Related]
14. Probing the stability-limiting regions of an antibody single-chain variable fragment: a molecular dynamics simulation study.
Wang T; Duan Y
Protein Eng Des Sel; 2011 Sep; 24(9):649-57. PubMed ID: 21729946
[TBL] [Abstract][Full Text] [Related]
15. DNA binding by the VH domain of anti-Z-DNA antibody and its modulation by association of the VL domain.
Chen Y; Stollar BD
J Immunol; 1999 Apr; 162(8):4663-70. PubMed ID: 10202006
[TBL] [Abstract][Full Text] [Related]
16. Different equilibrium stability behavior of ScFv fragments: identification, classification, and improvement by protein engineering.
Wörn A; Plückthun A
Biochemistry; 1999 Jul; 38(27):8739-50. PubMed ID: 10393549
[TBL] [Abstract][Full Text] [Related]
17. The scFv fragment of the antibody hu4D5-8: evidence for early premature domain interaction in refolding.
Jäger M; Gehrig P; Plückthun A
J Mol Biol; 2001 Feb; 305(5):1111-29. PubMed ID: 11162118
[TBL] [Abstract][Full Text] [Related]
18. Biophysical properties of human antibody variable domains.
Ewert S; Huber T; Honegger A; Plückthun A
J Mol Biol; 2003 Jan; 325(3):531-53. PubMed ID: 12498801
[TBL] [Abstract][Full Text] [Related]
19. Heat-induced native dimerization prevents amyloid formation by variable domain from immunoglobulin light-chain REI.
Nawata M; Tsutsumi H; Kobayashi Y; Unzai S; Mine S; Nakamura T; Uegaki K; Kamikubo H; Kataoka M; Hamada D
FEBS J; 2017 Sep; 284(18):3114-3127. PubMed ID: 28736891
[TBL] [Abstract][Full Text] [Related]
20. V
Fernández-Quintero ML; Hoerschinger VJ; Lamp LM; Bujotzek A; Georges G; Liedl KR
Proteins; 2020 Jul; 88(7):830-839. PubMed ID: 31904133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
